MONTREAL, QUEBEC--(MARKET WIRE)--Jun 9, 2006 -- IBEX Technologies Inc. (TSX:IBT.TO - News), an innovator in the development of diagnostics for the management of cancer and arthritis, and a supplier of high-purity glycobiology enzymes, today reported its financial results for the third quarter and nine-months ended April 30, 2006.
